It was found that SSc patients with higher CXCL4 levels in plasmacyte-like dendritic cell supernatant developed ILD significantly earlier, with a relative decline in forced vital capacity of over 30%, significantly faster decline in lung carbon monoxide diffusion capacity, and bilateral fibrosis on CT (22). The gene discussed is PF4; the disease is systemic sclerosis.